ARCHIVES

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

Piedmont, Mid-Atlantic Organizations Win Competition for NCI Support Of New Regional Cooperative Groups

April 16, 1982

Mass. Democrats, NCCS, To Provide Bracelets, Information In Honor Of Kennedy.

June 6, 2008

Long-Term Remissions Shown With Chemo Plus Radiation

September 29, 2006

Panel Unenthused About New Toxicity Testing Program

December 15, 1978